文献速递乳房整形与再造创面修复

无细胞真皮基质使用与否对胸肌前组织扩张器乳房再造早期并发症的影响

Early Complications after Prepectoral Tissue Expander Placement in Breast Reconstruction with and without Acellular Dermal Matrix.
PubMed 文献 · Plast Reconstr Surg · 2023-06-06

单中心回顾性研究纳入2020年8月至2022年1月连续124例胸肌前组织扩张器乳房再造患者,比较使用与不使用无细胞真皮基质(ADM)的90天术后结局。结果显示两组在血清肿、血肿、伤口裂开、皮瓣坏死、感染、非计划再手术及假体取出方面均无统计学显著差异。作者认为需更多研究评估不使用ADM的安全性。

要点

  • 使用与不使用ADM两组90天术后并发症及假体取出率无统计学显著差异。
  • 多变量分析控制年龄、BMI、糖尿病、吸烟、新辅助化疗和放疗后,ADM与各结局无独立关联。
  • 作者结论认为需更多研究评估不使用ADM的胸肌前组织扩张器置入安全性。

核心结论

  • 使用与不使用ADM的胸肌前组织扩张器乳房再造患者,术后并发症、非计划再手术或假体取出的比值无显著差异,作者认为需更多研究评估不使用ADM的安全性。

研究设计与样本

  • 单中心回顾性病历审查,纳入2020年8月至2022年1月连续接受胸肌前组织扩张器乳房再造的患者。
  • 共纳入124例连续患者,无ADM组55例(98侧乳房),ADM组69例(98侧乳房)。
  • 采用卡方检验比较人口学分类变量,多变量回归模型识别与3个月术后结局相关的变量。

主要发现

  • ADM组与无ADM组在90天术后结局方面无统计学显著差异。
  • 多变量分析控制年龄、体重指数、糖尿病史、吸烟、新辅助化疗和术后放疗后,血清肿、血肿、伤口裂开、乳房切除皮瓣坏死、感染、非计划返回手术室或假体取出在ADM组与无ADM组之间均无独立关联。

关键数值与推荐

  • 无ADM组55例患者(98侧乳房),ADM组69例患者(98侧乳房)。
  • 证据等级:治疗性,III级。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Prepectoral breast reconstruction has become popularized with the concurrent use of acellular dermal matrix (ADM). The authors sought to compare 3-month postoperative complication rates and explantation rates for first-stage, tissue-expander-based, prepectoral breast reconstruction with and without the use of ADM. METHODS: A single-institution retrospective chart review was performed to identify consecutive patients undergoing prepectoral tissue-expander-based breast reconstruction from August of 2020 to January of 2022. Chi-square tests were used to compare demographic categorical variables, and multiple variable regression models were used to identify variables associated with 3-month postoperative outcomes. RESULTS: The authors enrolled 124 consecutive patients. Fifty-five patients (98 breasts) were included in the no-ADM cohort and 69 patients (98 breasts) were included in the ADM cohort. There were no statistically significant differences between the ADM and no-ADM cohorts with regard to 90-day postoperative outcomes. On multivariable analysis, there were no independent associations between seroma, hematoma, wound dehiscence, mastectomy skin flap necrosis, infection, unplanned return to the operating room, or explantation in the ADM and no-ADM groups after controlling for age, body mass index, history of diabetes, tobacco use, neoadjuvant chemotherapy, and postoperative radiotherapy. CONCLUSIONS: The authors' results reveal no significant differences in odds of postoperative complications, unplanned return to the operating room, or explantation between the ADM and no-ADM cohorts. More studies are needed to evaluate the safety of prepectoral, tissue expander placement without ADM. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.

来源:Plast Reconstr Surg,查看原文。版权归原作者所有。

引用

  1. Pires G, Marquez JL, Memmott S, et al. Early Complications after Prepectoral Tissue Expander Placement in Breast Reconstruction with and without Acellular Dermal Matrix. Plast Reconstr Surg. 2023. PMID: 37285211. doi:10.1097/PRS.0000000000010801

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。